Generic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review

International Journal of Cancer

Volumn 69, Issue 3, 1996, Pages 225-235

  Montesano, Ruggero ^a   Hollstein, Monica ^b   Hainaut, Pierre ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; GROWTH FACTOR RECEPTOR; PROTEIN P53; REGULATOR PROTEIN;

ADENOCARCINOMA; CANCER SCREENING; CELL CYCLE; CHROMOSOME LOSS; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; ONCOGENE C MYC; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ALLELE; CHROMOSOME ABERRATION; ESOPHAGUS TUMOR; GENE DELETION; GENETICS; PATHOLOGY;

ADENOCARCINOMA; ALLELES; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; ESOPHAGEAL NEOPLASMS; GENE DELETION; HUMANS;

EID: 0029665180     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6     Document Type: Review

References (126)

1. ADELAIDE, J., MONGES, G., DERDERIAN, C., SEITZ, J.F. and BIRNBAUM, D., Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Brit. J. Cancer, 71, 64-68 (1995).
2. AL KASSPOOLES, M., MOORE, J.H., ORRINGER, M.B. and BEER, D.G., Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int. J. Cancer, 54, 213-219 (1993).
3. AOKI, T., MORI, T., DU, X., NISIHIRA, T., MATSUBARA, T. and NAKAMURA, Y., Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer, 10, 177-182 (1994).
4. AUDREZET, M.P., ROBASZKIEWICZ, M., MERCIER, B., NOUSBAUM, J.B., BAIL, J.P., HARDY, E., VOLANT, A., LOZAC'H, P., CHARLES, J.F., GOUÉRON, H. and FÉREC C., TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res., 53, 5745-5749 (1993).
5. BAKER, S.J., PREISINGER, A.C., JESSUP, J.M., PARASKEVA, C., MARKOWITZ, S., WILLSON, J.K., HAMILTON, S. and VOGELSTEIN, B., p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50, 7717-7722 (1990).
6. BENNETT, W.P., HOLLSTEIN, M.C., HE, A., ZHU, S.M., RESAU, J.H., TRUMP, B.F., METCALF, R.A., WELSH, J.A., MIDGLEY, C., LANE, D.P. and HARRIS, C., Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene, 6, 1779-1784 (1991).
7. BENNETT, W.P., HOLLSTEIN, M.C., METCALF, R.A., WELSH, J.A., HE, A., ZHU, S.M., KUSTERS, I., RESAU, J.H., TRUMP, B.F. and LANE, D.P., p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res., 52, 6092-6097 (1992).
8. BERRINO, F., SANT, M., VERDECCHIA, A., CAPACACCIA, R., HAKULINEN, T. and ESTÈVE, J., Survival of cancer patients in europe - the Eurocare Study, IARC, Lyon (1995).
9. BLOT, W.J., DEVESA, S.S. and FRAUMENI, J.F., Continuing climb in rates of esophageal adenocarcinoma: an update [letter]. J. amer. Med. Ass., 270, 1320 (1993).
10. BOYNTON, R.F., BLOUNT, P.L., YIN, J., BROWN, V.L., HUANG, Y., TONG, Y., MCDANIEL, T., NEWKIRK, C., RESAU, J.H., RASKIND, W.H., HAGITT, R.C., REID, B.J. and MELTZER, S.J., Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc. nat. Acad. Sci. (Wash.), 89, 3385-3388 (1992).
11. BOYNTON, R.F., HUANG, Y., BLOUNT, P.L., REID, B.J., RASKIND, W.H., HAGGITT, R.C., NEWKIRK, C., RESAU, J.H., YIN, J., MCDANIEL, T. and MELTZER, S.J., Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res., 51, 5766-5769 (1991).
12. BRENNAN, J.A., BOYLE, J.O., KOCH, W.M., GOODMAN, S.N., HRUBAN, R.H., EBY, Y.J., COUCH, M.J., FORASTIERE, A.A. and SIDRANSKY, D., Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332, 712-717 (1995).
13. BROWN, L.M., SILVERMAN, D.T., POTTERN, L.M., SCHOENBERG, J.B., GREENBERG, R.S., SWANSON, G.M., LIFF, J.M., SCHWARTZ, A.G., HAYES, R.B., BLOT, W.J. and HOOVER, R.N., Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control, 5, 333-340 (1994).
14. CAIRNS, P., and 20 OTHERS, Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature (Genet.), 11, 210-212 (1995).
15. CARTER, C.L., HU, N., WU, M., LIN, P.Z., MURIGANDE, C. and BONNEY, G.E., Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J. nat. Cancer Inst., 84, 771-776 (1992).
16. CASSON, A.G., MANOLOPOULOS, B., TROSTER, M., KERKVLIET, N., O'MALLEY, F., INCULET, R., FINLEY, R. and ROTH, J.A., Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. Amer. J. Surg., 167, 52-57 (1994).
17. CASSON, A.G., MUKHOPADHYAY, T., CLEARY, K.R., RO, J.Y., LEVIN, B. and ROTH, J.A., p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51, 4495-4499 (1991).
18. CHEN, P.L., CHEN, Y.M., BOOKSTEIN, R. and LEE, W.H., Genetic mechanisms of tumor suppression by the human p53 gene. Science, 250, 1576-1580 (1990).
19. CHIBA, I., TAKAHASHI, T., NAU, M.M., D'AMICO, D., CURIEL, D.T., MITSUDOMI, T., BUCHHAGEN, D.L., CARBONE, D., PIANTADOSI, S. and KOGA, H., Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene, 5, 1603-1610 (1990).
20. CHO, Y., GORINA, S., JEFFREY, P.D. and PAVLETICH, N.P., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355 (1994).
21. CHUNG, K.Y., MUKHOPADHYAY, T., KIM, J., CASSON, A., RO, J.Y., GOEPFERT, H., HONG, W.K. and ROTH, J.A., Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res., 53, 1676-1683 (1993).
22. D'AMICO, D., CARBONE, D.P., JOHNSON, B.E., MELTZER, S.J. and MINNA, J.D., Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res., 52, 1996-1999 (1992).
23. ENG, C., SPECHLER, S.J., RUBEN, R. and LI, P.P., Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol. Biomarkers. Prev., 2, 397-399 (1993).
24. ESTÈVE, A., LEHMAN, T., JIANG, W., WEINSTEIN, I.B., HARRIS, C.C., RUOL, A., PERACCHIA, A., MONTESANO, R. and HOLLSTEIN, M., Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol. Carcinogenesis, 8, 306-311 (1993).
25. ESTÈVE, A., MARTEL-PLANCHE, G., SYLLA, B.S., HOLLSTEIN, M. and MONTESANO, R., Low frequency of p16/CDKN2 gene mutations in esophageal squamous cell carcinomas. Int. J. Cancer 66, 301-304 (1996) in press.
26. ESTÈVE, A., SORLIE, T., MARTEL-PLANCHE, G., HOLLSTEIN, M., KUSTERS, I., LEWALTER, J., VINEIS, P., STEPHAN ODENTHAL, M. and MONTESANO, R., Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors. J. Occup. Environ. Med., 37, 59-68 (1995).
27. FEARON, E.R. and VOOELSTEIN, B., A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
28. FINLAY, C.A., HINDS, P.W. and LEVINE, A.J., The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57, 1083-1093 (1989).
29. FLÉJOU, J.F., PARAF, F., POTET, F., MUZEAU, F., FEKETE, F. and HÉNIN, D., p53 protein expression in Barrett's adenocarcinoma: a frequent event with no prognostic significance. Histopathology, 24, 487-489 (1994).
30. FRANKEL, R.H., BAYONA, W., KOSLOW, M. and NEWCOMB, E.W., p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res., 52, 1427-1433 (1992).
31. GAILANI, M.R. and 12 OTHERS, Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell, 69, 111-117 (1992).
32. GAO, H., WANG, L.D., ZHOU, Q., HONG, J.Y., HUANG, T.Y. and YANG, C.S., p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res., 54, 4342-4346 (1994).
33. GLEESON, C.M., SLOAN, J.M., MCGUIGAN, J.A., RITCHIE, A.J. and RUSSEL, S.E.H., Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res., 55, 3406-3411 (1995).
34. GLEESON, C.M., SLOAN, J. M., MCGUIGAN, J.A., RITCHIE, A.J., WEBER, J.L. and RUSSEL, S.E.H., Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma. Cancer Res., 56, 259-263 (1996).
35. GOUDIE, D.R., YUILLE, M.A., LEVERSHA, M.A., FURLONG, R.A., CARTER, N.P., LUSH, M.J., AFFARA, N.A. and FERGUSON SMITH, M.A., Multiple self-healing squamous epitheliomata (ESS1) mapped to chromosome 9q22-q31 in families with common ancestry. Nature (Genet.), 3, 165-169 (1993).
36. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
37. GREENWALD, B.D., HUANG, Y., BAUM, R. and MELTZER, S.J., Barrett's carcinoma in a 25 year old man with point mutation of the p53 tumor suppressor gene. Int. J. Oncol., 1, 271-275 (1992).
38. HAHN, S.A., SCHUTTE, M., HOQUE, A.T.M.S., MOSKALUK, C.A., DA COSTA, L.T., ROZENBLUM, E., WEINSTEIN, C.L., FISCHER, A., YEO, C.J., HRUBAN, R.H. and KERN, S.E., DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271, 350-353 (1996).
39. HAINAUT, P., The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol., 7, 76-82 (1995).
40. HAMELIN, R., FLÉJOU, J.F., MUZEAU, F., POTET, F., LAURENT PUIG, P., FEKETE, F. and THOMAS, G., TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology, 107, 1012-1018 (1994).
41. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.P., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
42. HOLLSTEIN, M.C., METCALF, R.A., WELSH, J.A., MONTESANO, R. and HARRIS, C.C., Frequent mutation of the p53 gene in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 87, 9958-9961 (1990).
43. HOLLSTEIN, M.C., PERI, L., MANDARD, A.M., WELSH, J.A., MONTESANO, R., METCALF, R.A., BAK, M. and HARRIS, C.C., Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51, 4102-4106 (1991).
44. HOLLSTEIN, M., SHORMER, B., GREENBLATT, M., SOUSSI, T., HOVIG, E., MONTESANO, R. and HARRIS, C.C., Somatic point mutations in the p53 gene of human tumors and cell lines: update compilation, Nucleic. Acids. Res., 24, 141-146 (1996).
45. HOLLSTEIN, M.C., SMITS, A.M., GALIANA, C., YAMASAKI, H., BOS, J.L., MANDARD, A., PARTENSKY, C. and MONTESANO, R., Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res., 48, 5119-5123 (1988).
46. HU, N., DAWSEY, S.M., WU, M., BONNEY, G.E., HE, L.J., HAN, X.Y., FU, M. and TAYLOR, P.R., Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int. J. Epidemiol., 21, 877-882 (1992).
47. HUANG, H.J.S., YEE, J.K., SHEW, J.Y., CHEN, P.L., BOOKSTEIN, R., FRIEDMANN, T., LEE, E.Y.H.P. and LEE, W.H., Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science, 242, 1563-1566 (1988).
48. HUANG, Y., BOYNTON, R.F., BLOUNT, P.L., SILVERSTEIN, R.J., YIN, J., TONG, Y., MCDANIEL, T.K., NEWKIRK, C., RESAU, J.H., SRIDHARA, R., REID, B.J. and MELTZER, S.J., Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res., 52, 6525-6530 (1992).
49. HUANG, Y., MELTZER, S.J., YIN, J., TONG, Y., CHANG, E.H., SRIVASTAVA, S., MCDANIEL, T., BOYNTON, R.F. and ZOU, Z.Q., Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res., 53, 1889-1894 (1993).
50. IARC, Human papillomaviruses. IARC monograph on the evaluation of carcinogenetic risk to humans, 64, (1995).
51. IGAKI, H., SASAKI, H., TACHIMORI, Y., KATO, H., WATANABE, H., KIMURA, T., HARADA, Y., SUGIMURA, T. and TERADA, M., Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res., 55, 3421-3423 (1995).
52. JIANG, W., ZHANG, Y.J., KAHN, S.M., HOLLSTEIN, M.C., SANTELLA, R.M., LU, S.H., HARRIS, C.C., MONTESANO, R. and WEINSTEIN, I.B., Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 90, 9026-9030 (1993).
53. KAMB, A., Cell-cycle regulators and cancer. Trends. Genet., 11, 136-140 (1995).
54. KAMB, A., GRUIS, N.A., WEAVER FELDMAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S., IIIRD, JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
55. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B. and CRAIG, R.W., Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311 (1991).
56. KEITH, W.N., DOUGLAS, F., WISHART, G.C., MCCALLUM, H.M., GEORGE, W.D., KAYE, S.B. and BROWN, R., Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase 1 on chromosome 20. Europ. J. Cancer, 29A, 1469-1475 (1993).
57. KINZLER, K.W. and 17 OTHERS, Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science, 251, 1366-1370 (1991).
58. KITAGAWA, Y., UEDA, M., ANDO, N., SHINOZAWA, Y., SHIMIZU, N. and ABE, O., Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res., 51, 1504-1508 (1991).
59. LASKO, D., CAVENEE, W. and NORDENSKIOLD, M., Loss of constitutional heterozygosity in human cancer. Ann. Rev. Genet., 25, 281-314 (1991).
60. LEVINE, D.S., Barrett's oesophagus and p53. Lancet, 344, 212-213 (1994).
61. LIANG, Y.-Y., ESTEVE, A., MAITEL-PLANCHE, G., TAKAHASHI, S., LU, S.-H., MONTESANO, R., AND HOLLSTEIN, M. p53 mutations in esophageal tumors from high-incidence areas of China. Int. J. Cancer, 61, 611-614 (1995).
62. LINDAHL, T., Instability and decay of the primary structure of DNA. Nature (Lond.), 362, 709-715 (1993).
63. LIU, S.F., and 14 OTHERS, Esophageal balloon cytology and subsequent risk of esophageal and gastric-cardia cancer in a high-risk Chinese population. Int. J. Cancer, 57, 775-780 (1994).
64. LU, S.H., HSIEH, L.L., LUO, F.C. and WEINSTEIN, I.B., Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int. J. Cancer, 42, 502-505 (1988).
65. 1 control in retinoblastoma genedeficient cells independently of cdk4 activity. Mol. cell. Biol., 15, 2600-2611 (1995).
66. MAESAWA, C., TAMURA, G., SUZUKI, Y., ISHIDA, K., SAITO, K. and SATODATE, R., Sensitive detection of p53 gene mutations in esophageal endoscopie biopsy specimens by cell sorting combined with polymerase chain reaction single-strand conformation polymorphism analysis. Jpn. J. Cancer Res., 83, 1253-1256 (1992).
67. MAESAWA, C., TAMURA, G., SUZUKI, Y., OGASAWARA, S., ISHIDA, K., SAITO, K. and SATODATE, R., Aberrations of tumor-suppressor genes (p53, apc, mcc and Rb) in esophageal squamous-cell carcinoma. Int. J. Cancer, 57, 21-25 (1994).
68. MELTZER, S.K., YIN, J., HUANG, Y., MCDANIEL, T.K., NEWKIRK, C., ISERI, O., VOGELSTEIN, B. and RESAU, J.H., Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 88, 4976-4980 (1991).
69. MIRONOV, N.M., AGUELON, A.M., HOLLAMS, E., LOZANO, J.C. and YAMASAKI, H., Microsatellite alterations in human and rat esophageal tumors at selective loci. Mol. Carcinogenesis, 13, 1-5 (1995).
70. MIYAKE, S., NAGAI, K., YOSHINO, K., OTO, M., ENDO, M. and YUASA, Y., Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res., 54, 3007-3010 (1994).
71. MONTESANO, R. and KIRBY, G.M., Chemical carcinogens in human liver cancer. In: C. Brechot (ed.), Primary liver cancer: etiological and progression factors, pp. 57-77, CRC Press, Boca Raton, FL (1994).
72. MOORE, J.H., LESSER, E.J., ERDODY, D.H., NATALE, R.B., ORRINGER, M.B. and BEER, D.G., Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma. Int. J. Cancer, 56, 487-493 (1994).
73. MORI, T., AOKI, T., MATSUBARA, T., IIDA, F., DU, X., NISHIHIRA, T., MORI, S. and NAKAMURA, Y., Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. Cancer Res., 54, 1638-1640 (1994a).
74. MORI, T., YANAGISAWA, A., KATO, Y., MIURA, K., NISHIHIRA, T., MORI, S. and NAKAMURA, Y., Accumulation of genetic alterations during esophageal carcinogenesis. Hum. mol. Genet., 3, 1969-1971 (1994b).
75. MUÑOZ, N. and CASTELLSAGUÈ, X., Epidemiology of oesophageal cancer. Europ. J. Gastroenterol. Hepatol., 6, 649-655 (1994).
76. NAKASHIMA, H., MORI, M., MIMORI, K., INDUE, H., SHIBUTA, K., BABA, K., MAFUNE, K.I. and AKIYOSHI, T., Microsatellite instability in Japanese esophageal carcinoma. Int. J. Cancer, 64, 286-289 (1995).
77. NEES, M., HOMANN, N., DISCHER, H., ANDL, T., ENDERS, C., HEROLD MENDE, C., SCHUHMANN, A. and BOSCH, F.X., Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res., 53, 4189-4196 (1993).
78. NESHAT, K., SANCHEZ, C.A., GALIPEAU, P.C., BLOUNT, P.L., LEVINE, D.S., JOSLYN, G. and REID, B.J., p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology, 106, 1589-1595 (1994a).
79. NESHAT, K., SANCHEZ, C.A., GALIPEAU, P.C., COWAN, D.S., RAMEL, S., LEVINE, D.S. and REID, B.J., Barrett's esophagus: a model of human neoplastic progression. Cold Spring Harbor Symp. quant. Biol., 59, 577-583 (1994b).
80. NISHISHO, I., NAKAMURA, Y., MIYOSHI, Y., MIKI, Y., ANDO, H., HORII, A., KOYAMA, K., UTSUNOMIYA, J., BABA, S. and HEDGE, P., Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665-669 (1991).
81. OGASAWARA, S., MAESAWA, C., TAMURA, G. and SATODATE, R., Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res., 55, 891-894 (1995).
82. OHGAKI, H., SCHAUBLE, B., ZUR HAUSEN, A., VON AMMON, K. and KLEIHUES, P., Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch., 427, 113-118 (1995).
83. OKAMOTO, A., DEMETRICK, D.J., SPILLARE, E.A., HAGIWARA, K., HUSSAIN, S.P., BENNETT, W.P., FORRESTER, K., GERWIN, B., SERRANO, M., BEACH, D.H. and HARRIS, C.C., Mutations and altered expression of p16INK4 in human cancer. Proc. nat. Acad. Sci. (Wash.), 91, 11045-11049 (1994).
84. PAPADOPOULOS, N. and 19 OTHERS, Mutation of a mutL homolog in hereditary colon cancer. Science, 263, 1625-1629 (1994).
85. PARKIN, D.M., PISANI, P. and FERLAY, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606 (1993).
86. PISANI, P., PARKIN, D.M. and FERLAY, J., Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int. J. Cancer, 55, 891-903 (1993).
87. POWELL, S.M., PAPADOPOULOS, N., KINZLER, K.W., SMOLINSKI, K.N. and MELTZER, S.J., APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology, 107, 1759-1763 (1994).
88. POWELL, S.M., ZILZ, N., BEAZER-BARCLAY, Y., BRYAN, T.M., HAMILTON, S.R., THIBODEAU, S.N., VOGELSTEIN, B. and KINZLER, K.W., APC mutations occur early during colorectal tumorigenesis. Nature (Lond.), 359, 235-237 (1992).
89. REID, B.J., BLOUNT, P.L., RUBIN, C.E., LEVINE, D.S., HAGGITT, R.C. and RABINOVITCH, P.S., Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopie surveillance of a cohort [see comments]. Gastroenterology, 102, 1212-1219 (1992).
90. RIDEOUT, W.M., IIIRD, COETZEE, G.A., OLUMI, A.F. and JONES, P.A., 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science, 249, 1288-1290 (1990).
91. RISK, J.M., FIELD, E.A., FIELD, J.K., WHITTAKER, J., FRYER, A., ELLIS, A., SHAW, J.M., FRIEDMANN, P.S., BISHOP, D.T., BOOMER, J. and LEIGH, I.M., Tylosis oesophageal cancer mapped. Nature (Genet.), 8, 319-321 (1994).
92. ROSEN, N., The molecular basis for cellular transformation: implications for esophageal carcinogenesis. Semin. Oncol., 21, 416-424 (1994).
93. ROTH, J.A., The cell and molecular biology of esophageal carcinoma. Chest Surg. Clin. North Amer., 4, 205-216 (1994).
94. SARBIA, M., PORSCHEN, R., BORCHARD, F., HORSTMANN, O., WILLERS, R. and GABBERT, H.E., p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer, 74, 2218-2223 (1994).
95. SCHRIER, P.I. and PELTENBURG, L.T., Relationship between myc oncogene activation and MHC class I expression. Adv. Cancer Res., 60, 181-246 (1993).
96. SCHULZE, A., ZERFASS, K., SPITKOVSKY, D., HENGLEIN, B. and JANSLN DURR, P., Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Oncogene, 9, 3475-3482 (1994).
97. SHEN, J.C., ZINGG, J.M., YANG, A.S., SCHMUTTE, C. and JONES, P.A., A mutant Hpall methyltransferase functions as a mutator enzyme. Nucleic Acids. Res., 23, 4275-4282 (1995).
98. SHIBAGAKI, I., SHIMADA, Y., WAGATA, T., IKENAGA, M., IMAMURA, M. and ISHIZAKI, K., Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res., 54, 2996-3000 (1994).
99. SHIMADA, M., HORII, A., SASAKI, S., YANAGISAWA, A., KATO, Y., YAMASHITA, K., OKAGAWA, K., YAMASAKI, K., ISHIGURO, S., INOUE, M., SHIOZAKI, H. and NAKAMURA, Y., Infrequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers of the esophagus and various other tissues. Jpn. J. Cancer Res., 86, 511-515 (1995).
100. SHIMAYA, K., SHIOZAKI, H., INOUE, M., TAHARA, H., MONDEN, T., SHIMANO, T. and MORI, T., Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch., 422, 271-276 (1993).
101. SHIN, D.M., KIM, J., RO, J.Y., HITTELMAN, J., ROTH, J.A., HONG, W.K. and HITTELMAN, W.N., Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54, 321-326 (1994).
102. SLAMON, D.J., CLARK, G.M., WONG, S.G., LEVIN, W.J., ULLRICH, A. and MCGUIRE, W.L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182 (1987).
103. SORSDAHL, K., CASSON, A.G., TROSTER, M., VAN MEYEL, D., INCULET, R. and CHAMBERS, A.F., p53 and ras gene expression in human esophageal cancer and Barrett's epithelium: a prospective study. Cancer Detect. Prev., 18, 179-185 (1994).
104. SPECHLER, S.J., ZEROOGIAN, J.M., ANTONIOLI, D.A., WANG, H.H. and GOYAL, R.K., Prevalence of metaplasia at the gastro-oesophageal junction. Lancet, 344, 1533-1536 (1994).
105. STEMMERMANN, G., HEFEELFINGER, S.C., NOFFSINGER, A., HUI, Y.Z., MILLER, M.A. and FENOGLIO PREISER, C.M., The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum. Pathol., 25, 968-981 (1994).
106. STONE, S., JIANG, P., DAYANANTH, P., TAVTIGIAN, S.V., KATCHER, H., PARRY, D., PETERS, G. and KAMB, A., Complex structure and regulation of the P16 (MTS1) locus. Cancer Res., 55, 2988-2994 (1995).
107. SUN, Y., HILDESHEIM, A., LANIER, A.E., CAO, Y., YAO, K.T., RAABTRAUB, N. and YANG, C.S., No point mutation but decreased expres- sion of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas. Oncogene, 10, 785-788 (1995).
108. SWIFT, A., RISK, J.M., KINGSNORTH, A.N., WRIGHT, T.A., MYSKOW, W. and FIELD, J.K., Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma. Brit. J. Cancer, 71, 995-998 (1995).
109. TAMURA, G., MAESAWA, C., SUZUKI, Y., SATODATE, R., ISHIDA, K. and SAITO, K., p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn. J. Cancer Res., 83, 559-562 (1992).
110. TARMIN, L., YIN, J., ZHOU, X., SUZUKI, H., JIANG, H.Y., RHYU, M.G., ABRAHAM, J.M., KRASNA, M.J., COTFRELL, J. and MELTZER, S.J., Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. Cancer Res., 54, 6094-6096 (1994).
111. THOMAS, R.M. and SOBIN, L.H., Gastrointestinal cancer. Cancer, 75, 154-170 (1995).
112. TISHLER, R.B., CALDERWOOD, S.K., COEEMAN, C.N. and PRICE, B.D., Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res., 53, 2212-2216 (1993).
113. TSUDA, T., TAHARA, E., KAJIYAMA, G., SAKAMOTO, H., TERADA, M. and SUGIMURA, T., High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res., 49, 5505-5508 (1989).
114. VICTOR, T., DU TOIT, R., JORDAAN, A.M., BESTER, A.J. and VAN HELDEN, P.D., No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers. Cancer Res., 50, 4911-4914 (1990).
115. WAGATA, T., ISHIZAKI, K., IMAMURA, M., SHIMADA, Y., IKENAGA, M. and TOBE, T., Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res., 51, 2113-2117 (1991).
116. WAGATA, T., SHIBAGAKI, I., IMAMURA, M., SHIMADA, Y., TOGUCHIDA, J., YANDELL, D.W., IKENAGA, M., TOBE, T. and ISHIZAKI, K., Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res., 53, 846-850 (1993).
117. WANG, D.Y., XIANG, Y.Y., TANAKA, M., LI, X.R., LI, J.L., SHEN, Q., SUGIMURA, H. and KINO, I., High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer, 74, 3089-3096 (1994).
118. WANG, L.D., SHI, ST., ZHOU, Q., GOLDSTEIN, S., HONG, J.Y., SHAO, P., QIU, S.L. and YANG, C.S., Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int. J. Cancer, 59, 514-519 (1994).
119. WANG, Y., You, M., REYNOLDS, S.H., STONER, G.D. and ANDERSON, M.W., Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res., 50, 1591-1595 (1990).
120. WU, M., HU, N. and WANG, X., Genetic factors in the etiology of esophageal cancer and the strategy for its prevention in high-incidence areas in Northern China. In: H.T. Lynch and T. Hirayama (eds.), Genetic epidemiology of cancer, pp. 188-202, CRC Press, Boca Raton, FL (1989).
121. YANG, A.S., SHEN, J.C., ZINGG, J.M., Ml, S. and JONES, P.A., Hhal and Hpall DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Res., 23, 1380-1387 (1995).
122. YOSHIDA, T., SAKAMOTO, H. and TERADA, M., Amplified genes in cancer in upper digestive tract. Semin. Cancer Biol., 4, 33-40 (1993).
123. YOUNES, M., LEBOVITZ, R.M., LECHAGO, L.V. and LECHAGO, J., p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. Gastroenterology, 105, 1637-1642 (1993).
124. ZHAN, Q., CARRIER, F. and FORNACE, A.J., Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. cell. Biol., 13, 4242-4250 (1993).
125. ZHANG, S.Y., KLEIN-SZANTO, A.J., SAUTER, E.R., SHAFARENKO, M., MITSUNAGA, S., NOBORI, T., CARSON, D.A., RIDGE, J.A. and GOODROW, T.L., Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54, 5050-5053 (1994).
126. ZHOU, X., TARMIN, L., YIN, J., JIANG, H.Y., SUZUKI, H., RHYU, M.G., ABRAHAM, J.M. and MELTZER, S.J., The MTSI gene is frequently mutated in primary human esophageal tumors. Oncogene, 9, 3737-3741 (1994).